Legend Biotech (LEGN) Prepaid Assets (2019 - 2025)
Legend Biotech (LEGN) reported Prepaid Assets of $253.4 million for Q4 2025, up 93.44% on a YoY basis from $131.0 million in Q4 2024, and up 15.71% quarter-over-quarter from $219.0 million in Q3 2025.
Legend Biotech (LEGN) Prepaid Assets (2019 - 2025) Analysis & Trends
Legend Biotech has reported Prepaid Assets for 7 years, with the latest figure at $253.4 million in Q4 2025.
- For the quarter ending Q4 2025, Prepaid Assets rose 93.44% year-over-year to $253.4 million; the trailing twelve-month figure through Dec 2025 stood at $253.4 million (up 93.44% YoY), and the FY2025 full-year result was $253.4 million, up 93.44% from the prior year.
- Prepaid Assets for Q4 2025 stood at $253.4 million, up from $219.0 million in the prior quarter.
- The five-year high for Prepaid Assets was $253.4 million in Q4 2025, with the low at $10425.0 in Q1 2021.
- Historically, Prepaid Assets has averaged $93.2 million across 5 years, with a median of $67.9 million in 2023.
- Annual changes were most pronounced in 2022 — Prepaid Assets jumped 183132.61% — and 2023, when it grew 12.14%.
- Legend Biotech's Prepaid Assets stood at $13.9 million in 2021, then soared by 345.82% to $61.8 million in 2022, then grew by 12.14% to $69.3 million in 2023, then surged by 89.17% to $131.0 million in 2024, then jumped by 93.44% to $253.4 million in 2025.
- The last three Prepaid Assets figures came in at $253.4 million (Q4 2025), $219.0 million (Q3 2025), and $219.1 million (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Regeneron Pharmaceuticals | 63.43 Bn | 54.67 Bn | 3.31 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 253.40 Mn |
| Sep 30, 2025 | 218.99 Mn |
| Jun 30, 2025 | 219.08 Mn |
| Mar 31, 2025 | 182.04 Mn |
| Dec 31, 2024 | 131.00 Mn |
| Sep 30, 2024 | 112.80 Mn |
| Jun 30, 2024 | 100.63 Mn |
| Mar 31, 2024 | 85.60 Mn |
| Dec 31, 2023 | 69.25 Mn |
| Sep 30, 2023 | 66.57 Mn |
| Jun 30, 2023 | 66.57 Mn |
| Mar 31, 2023 | 51.76 Mn |
| Dec 31, 2022 | 61.76 Mn |
| Mar 31, 2022 | 19.10 Mn |
| Dec 31, 2021 | 13.85 Mn |
| Sep 30, 2021 | 13.84 Mn |
| Jun 30, 2021 | 11.17 Mn |
| Mar 31, 2021 | 10,425.00 |
| Dec 31, 2020 | 10.45 Mn |
| Sep 30, 2020 | 24,662.00 |